References: 1. Australian Institute of Health and Welfare (2024). Australian Burden of Disease Study 2024: Summary. Canberra: AIHW. Available at: www.aihw.gov.au/reports/burden-of-disease/australian-burden-of-disease-study-2024/contents/summary (accessed January 2026) 2. Castelluccia A, et al. Int J Environ Res Public Health. 2022;19:10800. 3. Hall WA, et al. CA Cancer J Clin. 2022;72:34–56. 4. Kadhum M, et al. J Hand Surg Eur. Vol 2017;42(7):689–692. 5. de Haan A, et al. Radiother Oncol. 2023;185:109718. 6. de Haan A, et al. Radiother Oncol. 2022;168:83–88. 7. Badakshi H, Buadch V. Foot (Edinb). 2014;24(4):172–175. 8. Ott OJ, et al. Strahlenther Onkol. 2015;191:1–6. 9. Walsh LA, et al. Syst Rev. 2023;12(1):42. 10. Australian Government. Cancer Australia. Breast Cancer in Australia statistics. Available from: www.canceraustralia.gov.au/cancer-types/breast-cancer/breast-cancer-australia-statistics (accessed January 2026). 11. Australian Government. Cancer Australia. Prostate Cancer in Australia statistics. Available from: www.canceraustralia.gov.au/cancer-types/prostate- cancer/prostate-cancer-australia-statistics (accessed January 2026). 12. Article in press 13. Article in press 14. Carr ME, et al. Medical Physics. 2025;52(6):4120-4133. 15. Higuchi S, et al. 2025. Computed Apparent Diffusion Coefficient in prostate cancer for treatment response monitoring: an MR-Linac feasibility study. Abstract. Presented at Magnetic Resonance in Radiation Therapy, New York City, 2025.

genesiscare.com

AU_5594_D_v1

Made with FlippingBook Annual report maker